Aker BioMarine AS/Nkr AKBM
07:00
08:50
10:40
12:30
14:20
1D1W1MYTD1Y5YMAX
About Aker BioMarine AS
Aker BioMarine AS is a biotechnology company focused on the sustainable harvesting, production, and distribution of krill-based products. Its core business operates within the marine biotechnology industry, emphasizing krill-derived ingredients for the health and nutrition sectors. The company's main products include krill oil for human consumption, utilized in dietary supplements, and krill meal used in feed for aquaculture. Headquartered in Oslo, Norway, Aker BioMarine maintains operations in the Southern Ocean where it conducts its krill harvesting activities. A unique aspect of its strategic positioning is its commitment to sustainability, which is underpinned by proprietary technology and practices designed to minimize environmental impact and ensure the responsible management of marine resources.
Ticker
Nkr AKBM
Sector
Primary listing
XOSL
Employees
258
Headquarters
Lysaker, Norway
Website
AKBM Metrics
BasicAdvanced
kr 8.3bn
-
-kr 1.04
0.29
-
Price and volume
Market cap
kr 8.3bn
Beta
0.29
52-week high
kr 118.00
52-week low
kr 74.70
Average daily volume
21k
Financial strength
Current ratio
2.599
Quick ratio
0.897
Long term debt to equity
130.684
Total debt to equity
150.699
Interest coverage (TTM)
0.65%
Profitability
EBITDA (TTM)
224.349
Gross margin (TTM)
45.03%
Net profit margin (TTM)
-5.85%
Operating margin (TTM)
6.47%
Effective tax rate (TTM)
-5.26%
Revenue per employee (TTM)
kr 8,509,770
Management effectiveness
Return on assets (TTM)
2.34%
Return on equity (TTM)
-7.01%
Valuation
Price to revenue (TTM)
5.259
Price to free cash flow (TTM)
-72.861
Free cash flow yield (TTM)
-1.37%
Free cash flow per share (TTM)
-1.287
Growth
Revenue change (TTM)
9.55%
Earnings per share change (TTM)
-103.16%
3-year revenue growth (CAGR)
-2.01%
10-year revenue growth (CAGR)
7.53%
3-year earnings per share growth (CAGR)
-16.29%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.